Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

X Cai

Showing results (671-680 of 898) with videos related to

Pageof 90
Sort By:
Journal of Medicinal Chemistry|March 15, 2000
Synthesis of N-substituted 4-(4-hydroxyphenyl)piperidines, 4-(4-hydroxybenzyl)piperidines, and (+/-)-3-(4-hydroxyphenyl)pyrrolidines: selective antagonists at the 1A/2B NMDA receptor subtypeA P Guzikowski, A P Tamiz, M Acosta-Burruel, et al.
Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics|December 28, 2023
[Clinical characteristics and prognosis of 28 cases of infant acute lymphoblastic leukemia]Y Shi, Y Lu, R D Zhang, et al.
Leukemia|April 10, 2012
Clinical utility and implications of asparaginase antibodies in acute lymphoblastic leukemiaC Liu, J D Kawedia, C Cheng, et al.
Journal of the National Cancer Institute|May 18, 1999
Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrationsX H Zhu, Y L Shen, Y K Jing, et al.
Physical Review Letters|June 1, 2004
Electron-electron interaction in strong electromagnetic fields: the two-electron contribution to the ground-state energy in He-like uraniumA Gumberidze, Th Stöhlker, D Banaś, et al.
Journal of Medicinal Chemistry|July 30, 1999
4-Hydroxy-1-[2-(4-hydroxyphenoxy)ethyl]-4-(4-methylbenzyl)piperidine: a novel, potent, and selective NR1/2B NMDA receptor antagonistZ L Zhou, S X Cai, E R Whittemore, et al.
JAMA Ophthalmology|June 8, 2023
Accuracy of Artificial Intelligence in Estimating Best-Corrected Visual Acuity From Fundus Photographs in Eyes With Diabetic Macular EdemaWilliam Paul, Philippe Burlina, Rohita Mocharla, et al.
Clinical Pharmacology and Therapeutics|December 13, 2016
Validation of a microdose probe drug cocktail for clinical drug interaction assessments for drug transporters and CYP3AT Prueksaritanont, D A Tatosian, X Chu, et al.
Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery|May 22, 2023
[Short-course radiotherapy combined with CAPOX and PD-1 inhibitor for the total neoadjuvant therapy of locally advanced rectal cancer: the preliminary single-center findings of a prospective, multicentre, randomized phase II trial (TORCH)]Y Q Wang, L J Shen, J F Wan, et al.
Antonie Van Leeuwenhoek|November 27, 2002
The molecular basis of co-evolution between Cladosporium fulvum and tomatoPierre J G M de Wit, B F Brandwagt, H A van den Burg, et al.
Pageof 90

Showing results (671-680 of 898) with videos related to

Sort By:
Pageof 90
Journal of Medicinal Chemistry|March 15, 2000
Synthesis of N-substituted 4-(4-hydroxyphenyl)piperidines, 4-(4-hydroxybenzyl)piperidines, and (+/-)-3-(4-hydroxyphenyl)pyrrolidines: selective antagonists at the 1A/2B NMDA receptor subtypeA P Guzikowski, A P Tamiz, M Acosta-Burruel, et al.
Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics|December 28, 2023
[Clinical characteristics and prognosis of 28 cases of infant acute lymphoblastic leukemia]Y Shi, Y Lu, R D Zhang, et al.
Leukemia|April 10, 2012
Clinical utility and implications of asparaginase antibodies in acute lymphoblastic leukemiaC Liu, J D Kawedia, C Cheng, et al.
Journal of the National Cancer Institute|May 18, 1999
Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrationsX H Zhu, Y L Shen, Y K Jing, et al.
Physical Review Letters|June 1, 2004
Electron-electron interaction in strong electromagnetic fields: the two-electron contribution to the ground-state energy in He-like uraniumA Gumberidze, Th Stöhlker, D Banaś, et al.
Journal of Medicinal Chemistry|July 30, 1999
4-Hydroxy-1-[2-(4-hydroxyphenoxy)ethyl]-4-(4-methylbenzyl)piperidine: a novel, potent, and selective NR1/2B NMDA receptor antagonistZ L Zhou, S X Cai, E R Whittemore, et al.
JAMA Ophthalmology|June 8, 2023
Accuracy of Artificial Intelligence in Estimating Best-Corrected Visual Acuity From Fundus Photographs in Eyes With Diabetic Macular EdemaWilliam Paul, Philippe Burlina, Rohita Mocharla, et al.
Clinical Pharmacology and Therapeutics|December 13, 2016
Validation of a microdose probe drug cocktail for clinical drug interaction assessments for drug transporters and CYP3AT Prueksaritanont, D A Tatosian, X Chu, et al.
Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery|May 22, 2023
[Short-course radiotherapy combined with CAPOX and PD-1 inhibitor for the total neoadjuvant therapy of locally advanced rectal cancer: the preliminary single-center findings of a prospective, multicentre, randomized phase II trial (TORCH)]Y Q Wang, L J Shen, J F Wan, et al.
Antonie Van Leeuwenhoek|November 27, 2002
The molecular basis of co-evolution between Cladosporium fulvum and tomatoPierre J G M de Wit, B F Brandwagt, H A van den Burg, et al.
Pageof 90